Home
James R. Kasinger, General Counsel and Secretary: Crispr Therapeutics CRSP Sell · Filed 25/02/19
Trade details
- Type
- Insider sale
- Amount
- $516,690.75
- Shares · price
- 9,595 sh · $53.85 a share
- Held after
- 73,002 sh
- Trade date
- 25/02/18
- Filed
- 25/02/19
- Days to filing
- 1 days
Sold 11.6% of holdings
- Share of holding sold
- 11.6%
Crispr Therapeutics trades, last 26 weeks
What else happened in Crispr Therapeutics around then
Filed or reported within 30 days of the trade day · 25/01/19~25/03/20James R. Kasinger's recent trades
- James R. Kasinger
Sell10b5-1 planCrispr Therapeutics
Sell10b5-1 planCrispr Therapeutics
CRSP
$626.5K
10,400 sh
$626.5K
Filed 09/24
Traded 09/22
- James R. Kasinger
Planned sale10b5-1 planCrispr Therapeutics
Planned sale10b5-1 planCrispr Therapeutics
CRSP
$626.5K
10,400 sh
$626.5K
Filed 09/22
Traded 09/22
- James R. Kasinger
SellCrispr Therapeutics
SellCrispr Therapeutics
CRSP
$148.9K
3,182 sh
$148.9K
Filed 03/24
Traded 03/23
- James R. Kasinger
SellCrispr Therapeutics
SellCrispr Therapeutics
CRSP
$166.5K
3,450 sh
$166.5K
Filed 03/17
Traded 03/16
- James R. Kasinger
SellCrispr Therapeutics
SellCrispr Therapeutics
CRSP
$147.8K
2,800 sh
$147.8K
Filed 03/12
Traded 03/11